My insurance denied Wegovy. Are compounded GLP-1s my best option?

Short answer: usually no — compounded GLP‑1s are rarely the best first option. They carry safety, quality, legal, and insurance problems. Try appeals, manufacturer help, or an FDA‑approved alternative first. If you still consider compounding, do it only as a last resort and only from a highly accredited compounder.

Why compounded GLP‑1s are risky or undesirable

• Not FDA‑approved for safety, purity, potency, sterility or efficacy the way brand products are.
• Lot‑to‑lot variability and possible dosing errors.
• Higher risk of contamination/infection if sterile technique isn’t perfect.
• Little or no clinical data on compounded versions (so unknown benefits/risks).
• Insurers almost never cover compounded biologics; you’ll likely pay out of pocket.
• Potential legal/regulatory gray areas for compounding patented/approved biologics.

Better next steps (practical, in order)

1. Appeal the denial

• Ask your prescriber to submit a prior authorization or a peer‑to‑peer review and a letter of medical necessity describing BMI, comorbidities (HTN, DM2, OSA, etc.), and prior weight‑loss attempts.
• Ask the insurer the exact reason for denial and what documentation would change the decision. Many approvals happen on appeal.

1. Check manufacturer support and savings

• Novo Nordisk (Wegovy) offers patient support and sometimes savings programs — contact Wegovy/Reimbursement Support via wegovy.com or ask your clinic to contact Novo Nordisk’s patient support.
• Lilly has assistance programs for Zepbound (tirzepatide) and for other products; patient assistance can reduce cost for eligible people. Ask your clinician to check manufacturer copay programs or PAPs.

1. Consider other FDA‑approved options

• Zepbound (tirzepatide, Eli Lilly) — FDA‑approved for chronic weight management. Some insurers cover it when Wegovy is denied.
• Saxenda (liraglutide, Novo Nordisk) — older GLP‑1 approved for weight management.
• If you have type 2 diabetes, Ozempic (semaglutide) or Mounjaro (tirzepatide) may be prescribed for glycemic control and sometimes covered; discuss risks/benefits with your clinician (they are not the same labeled dose for weight loss as Wegovy or Zepbound).
  Ask your clinician which alternative might be effective and more likely to be covered.

1. Use telemedicine or specialty weight‑management clinics (if access helps)

• Telehealth services that regularly work with coverage and prior auths include Hims & Hers, Ro, PlushCare, and specialty clinics like Virta or Obesity Medicine specialists. They may help navigate appeals, alternative medicines, or manufacturer programs.

1. Price comparison tools

• Use GoodRx or singlecare to compare retail prices and coupons for alternatives, but note coupons often don’t apply to branded specialty drugs or when insurance is involved.

If you still consider compounded GLP‑1s (only if other options fail)

• Only use a compounding pharmacy accredited by a recognized body (look for PCAB accreditation and documented USP <797>/<800> sterile compounding compliance).
• Ask the pharmacy for certificate of analysis, sterility testing, batch records, and exact dosing/expiration info.
• Discuss with your prescriber the exact compound formulation and monitoring plan.
• Be prepared to pay out of pocket and understand you lose the safety net of FDA labeling/data.

If you want, I can:

• Draft a short template letter of medical necessity for your prescriber to use in an appeal.
• Help you compare likely alternatives (Zepbound vs Saxenda vs off‑label options) based on your medical history.
  Which would be most helpful?